Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta analysis

Journal of Research in Medical Sciences

Volumn 18, Issue 8, 2013, Pages 674-682

  Khodabandehloo, Mazaher ^a   Roshani, Daem ^a   Sayehmiri, Kourosh ^b  

^a KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood donors; Hepatitis C virus; Iran; Prevalence; Seroepidemiology; Transfusion

Indexed keywords

ARTICLE; BLOOD DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRAN; META ANALYSIS; PREVALENCE; RISK FACTOR; SAMPLE SIZE; SYSTEMATIC REVIEW;

EID: 84884777682     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Hassanshahi G, Arababadi MK, Assar S, Hakimi H, Karimabad MN, Abedinzadeh M, et al. Post-transfusion-transmited hepatitis C virus infection: A study on thalassemia and hemodialysis patients in southeastern Iran. Arch Virol 2011;156:1111-1115.
2. Alavian SM. Hepatitis C infection in Iran; A review article. Iranian Journal of Clinical Infectious Diseases (ICID) 2009;4:47-59.
3. Gao X, Cui Q, Shi X, Su J, Peng Z, Chen X, et al. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: A systematic review and meta-analysis. BMC Infect Dis 2011;11:88.
4. Doosti A, Amini-Bavil-Olyaee S, Tajbakhsh E, Adeli A, Mahboudi F. Prevalence of viral hepatitis and molecular analysis of HBV among voluntary blood donors in west Iran. New Microbiol 2009;32:193-198.
5. Fallahian F, Najaf A. Epidemiology of hepatitis C in the middle East. Saudi J Kidney Dis Transpl 2011;22:1-9.
6. Amini Kafi-abad S, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009;49:2214-2220.
7. Khedmat H, Fallahian F, Abolghasemi H, Alavian SM, Hajibeigi B, Miri SM, et al. Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodefciency virus and syphilis infections in Iranian blood donors. Pak J Biol Sci 2007;10:4461-4466.
8. Sharif Z, Mahmoudian Shooshtari M. Hepatitis C virus infection and genotypes in blood donors. Iran J Virol 2008;2:17-22.
9. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: The first population-based study from Iran. Int J Infect Dis 2010;14 Suppl 3:e113-e116.
10. Keramat F, Eini P, Majzoobi M. Seroprevalence of HIV, HBV and HCV in persons referred to hamadan behavioral counseling center, West of Iran. Iran Red Crescent Med J 2011;13:42-46.
11. Khedmat H, Alavian SM, Miri SM, Amini M, Abolghasemi H, Hajibeigi B, et al. Trends in seroprevalence of hepatitis B, hepatitis C, HIV and Syphilis infections in Iranian blood donors from 2003 to 2005. Hepat Mon 2009;9:24-28.
12. Abolghasemi H, Maghsudlu M, Amini Kaf-Abad S, Cheraghali A. Introduction to Iranian blood transfusion organization and blood safety in Iran. Iran J Public Health 2009;38:82-87.
13. Omid Khoda A, Gharehbaghian A, Jamali M, Ahmad Beigi N, Hashemi S, Rahimi A, et al. Comparison of the prevalence of major transfusion-transmited infections among Iranian blood donors using confidential unit exclusion in an Iranian population. Hepat Mon 2011;1:11-13.
14. Sharif S, Atarchi Z. Comparison of first time and repeated donors blood test results. Northern center region blood transfusion Bultin (in Persian) 54:1-6.
15. Attarchi Z, Ghafouri M, Hajibaygi B, Assari S, Alavian SM. Donor deferral and blood-borne infections in blood donors of Tehran (in Persian). Sci J Iranian Blood Transfus Organ 2006;2:353-364.
16. Pourshams A, Malekzadeh R, Monavvari A, Akbari MR, Mohamadkhani A, Yarahmadi S, et al. Prevalence and etiology of persistently elevated alanine amino transferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol 2005;20:229-233.
17. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: A case-control study. J Gastroenterol Hepatol 2002;17:1092-1097.
18. Taheri Azbarmi Z, Nouri S, Joukar F, Jafarshad R, Haajikarimian K, Alinejad S, et al. Transfusion transmitted diseases in Rasht blood donors (in Persian). Sci J Iranian Blood Transfus Organ 2008;4:337-343.
19. Mansour-Ghanaei F, Fallah M, Jafarshad R, Joukar F, Salari A, Tavafzadeh R. Prevalence of hepatitis B surface antigen and hepatitis C virus antibody and their risk factors among Guilan's volunteer blood donors (1998-2003). Hepat Mon 2007;7:239-241.
20. Mansour Ghanaei HR, Fallah MS, Jafarshad R, Joukar F, Salari A, Tavafzadeh R, et al. Prevalence of hepatitis B and hepatitis C, and their risk factors among Guilan blood donors (in Persian). Sci J Iranian Blood Transfus Organ 2008 4(5):331-336.
21. Habibzadeh S, Davarnia B, Bazazataei A, Bagherzadeh S, Hamid Kholgh GR. Epidemiological evaluation of transfusion transmitted diseases in Ardabil in Tasoua and Ashoura 1381(2003) (in Persian). Sci J Iranian Blood Transfus Organ 2003;1:55-60.
22. Bozorgi S, Ahmadzad Asl M, Ramezani H, Kargarfard H, Alavian S. Study of viral infections prevalence in blood donors of qazvin province in different time intervals and during bam earthquake (in Persian). Govaresh 2006;11:242-248.
23. Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, et al. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis 2010;14:e308-e310.
24. Mahdaviani F, Saremi S, Maghsoudlu M, Pourfathollah AA. Prevalence of blood transmited viral infections in regular and non-regular donors of Arak Blood Center (in Persian). Sci J Iranian Blood Transfus Organ 2006;2:343-351.
25. Tavallaei SG. The prevalence of hepatitis C virus among blood donors in Markazi province (in Persian). Journal of Arak University of Medical Sciences 2000;3:11-15.
26. Moniri R, Mosayebii Z, Mossavi G. Seroprevalence of Cytomegalovirus, Hepatitis B, Hepatitis C and human immunodeficiency virus antibodies among volunteer blood donors. Iran J Public Health 2004;33:38-42.
27. Afzali H, Taghavi Ardakani A, Vali GR. Seroepidemiology of Hepatitis B and C in blood donors in Kashan, 1996-2001(in Persian). Feyz. Kashan University of Medical Sciences and Health Services 2002;6:43-50.
28. Delavari M, Tabatabaie SM, Sheikh Bardsiri H, Maarefdust Z, Zandieh T. The prevalence of Hepatitis C and its related factors among blood donors of Kerman Blood Center (in Persian). Sci J Iranian Blood Transfus Organ 2006;2:269-271.
29. Delavari M, Tabatabaei S. Frequency of Hepatitis C and its related factors in blood donors in Kerman in 2003 (in Persian). Journal of Army University of Medical Sciences (JAUMS) 2004;2:353-357.
30. Kasraian L, Tavassoli AR. Prevalence of hepatitis C and its risk factors in blood donors at Shiraz transfusion center (in Persian). Koomesh, Journal of Semnan University of Medical Sciences 2008;10:7-12.
31. Kasraian L, Tavasoli A. Positivity of HIV, hepatitis B and hepatitis C in patients enrolled in a confidential self-exclusion system of blood donation: A cross-sectional analytical study. Sao Paulo Med J 2010;128:320-323.
32. Kasraian L. Survay the rate of blood donors loss due to unconfirmed ELISA test in blood transfusion organization in Fars province (in Persian). Journal of Guilan University of Medical Science 2008;67:80-87.
33. Kasraian L, Torab Jahromi SA. Study of confdential self-exclusion cases in Shiraz regional blood transfusion center (in Persian). Daneshvar 2008;15:71-78.
34. Kasraian L, Torab Jahromi SA. Prevalence of major Transfusion-transmissible viral infections in blood donors atending fars blood transfusion center, Shiraz, Southern Iran: 2002-05. Iran J Med Sci 2007;32:114-117.
35. Kasraian L, Torab Jahromi SA. Prevalence of major transfusion transmitted viral infections (HCV, HBV, HIV) in Shiraz blood donors from 2000 to 2005 (in Persian). Sci J Iranian Blood Transfus Organ 2007;3:373-378.
36. Kasraian L, Torab-Jahromi S. The effect of Bam earthquake on blood supply and safety in Shiraz blood transfusion organization, winter 1382 (in Persian). Journal of Shahrekord University of Medical Sciences Journal (JSKUMS) 2008;1:9-13.
37. Kasraian L. National disasters in Iran and blood donation: Bam earthquake experience. Iran Red Crescent Med J 2010;12:316-318.
38. Ghavanini A, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J 2000;6:1114-1116.
39. th International Congress on Infectious Diseases Abstracts, Poster Presentations; International Journal of Infectious Diseases 12 (1) 2008. P. e87-e88.
40. Javadzadeh Shahshahani H. Comparison of the positive predicative value of two enzyme immunoassay screening kits for hepatitis C in blood donors (in Persian). Sci J Iranian Blood Transfus Organ 2007;4:51-57.
41. Salman Roghani H. Prevalence of Hepatitis B Ab with or without anti-HBSAb in HBSAg seronegative blood donors (in Persian). Journal of Shaheed Sadoughi University of Medical Sciences and Health services 2005;12:10-16.
42. Mardani A, Hosseini S, Kheirkhahi N. Study of confidential self-exclusion cases in Qom Regional Blood Transfusion Center (in Persian). Sci J Iranian Blood Transfus Organ 2006;3:183-189.
43. Agha Jani Poor K, Zandieh T. Seroepidemiological investigation of hepatitis B, C and HIV virus in safe blood donors of Babol Blood Transfusion Center (in Persian). Sci J Iranian Blood Transfus Organ 2006;2:339-341.
44. Salehi H, Salehi M, Khish Ardestani M, Khorvash F, Mz K. Comparison of the blood safety from Viral makers of B and C hepatitis, AIDS and Addiction, on the blood donors within the religious ceremonies and routine conditions (in Persian). Journal of Isfahan Medical School 2011;28:56-62.
45. Pourazar A, Akbari N, Hariri M, Yavari F, Akbari S. Evaluation of demographic profiles and prevalence of major viral markers in frst time vs repeat blood donors in Esfahan (in Persian). Sci J Iranian Blood Transfus Organ 2006;2:323-329.
46. Masaeli Z, Jaberi MR, Magsudlu M. A comparison of seroprevalence of blood-borne infections among regular, sporadic, and first-time blood donors in Isfahan (in Persian). Sci J Iranian Blood Transfus Organ 2006;2:301-307.
47. Kazemi Nejad V, Azar Housh R, Molana A, Dehbashi GR. Frequency of Hepatitis B virus, Hepatitis C virus and human immunodeficiency virus in blood donors and patients in Gorgan Blood Transfusion Organization in 2003 (in Persian). Journal of Gorgan University of Medical Sciences 2005;15:84-86.
48. Bani Aghil S, Abbasi S, Arab M, Seyedein MS. The Prevalence of HCV, HBV, HIV in Blood Donors of Golestan (in Persian). Medical Laboratory Journal 2009;2:1-5.
49. Nour Kojory S, Alaoddowleie H, Seddighian F. Efficacy of confidential self-exclusion and failed systems on blood donation safety in Sari and Behshahr blood donors (in Persian). Sci J Iranian Blood Transfus Organ 2007;4:153-158.
50. Ghafouri M, Ameli MR. Comparing prevalence of transfusion transmitted viral infections in various population groups of South Khorasan (in Persian). Blood SJIBTO 2011;7:242-248.
51. Esmaieli H. Seroepidemiological survey of hepatitis B, C, HIV and syphilis among blood donors in Bushehr-Iran (in Persian). Iranian South Medical Journal 2009;2:183-190.
52. Emamghorashi F, Fathi GH, Mohtashami A. Evaluation of demographic characteristics and hepatitis B, C and HIV prevalence among blood donors in Jahrom (in Persian). Sci J Iranian Blood Transfus Organ 2006;2:373-378.
53. Sanei Moghaddam E, Khosravi S, Gharibi T. Prevalence of HBsAg and Anti-HCV reactivity in donors embarking on direct blood donation and among first-time blood donors in Zahedan Blood Transfusion Center. Blood SJIBTO 2005;1:19-25.
54. Vossoughinia H, Taghi Shakeri M, Mokhtari Amirmajdi E, Ravan bakhsh F, Abedini S. Risk factors for hepatitis B and C in 400 blood donor volunteers in mashhad during 2003-2007: A case-control study (in Persian). Ofogh-e-Danesh (Ufuq-i dānish) 2010;16:68-76.
55. Farshadpour F, Makvandi M, Samarbafzadeh AR, Jalalifar MA. Determination of hepatitis C virus genotypes among blood donors in Ahvaz, Iran. Indian J Med Microbiol 2010;28:54-56.
56. Nabavizadeh SH, Haghbeen S. Prevalence of blood transmitted infection in donors of Yasuj blood transfusion organization (in Persian). Journal of Guilan University of Medical Sciences 2000;35:64-67.
57. Jabbari H, Karami S, Fatahi F, Jam S, Mohraz M. "Seroprevalence of Human Immunodeficiency Virus, Hepatitis B and C viruses among blood donors in Chabahar Iran." International Journal of Infectious Diseases 2008;12, Supplement 1(0):e424.
58. Sadeghi A, Shariat Zadeh M, Lamei A. Evaluation of the prevalence of hepatitis C virus (HCV) among blood donors in Urmia transfusion center (in Persian). Urmia Medical Journal 1999;9:242-248.
59. Tajbakhsh E, Yaghobi R, Vahedi A. A serological survey on hepatitis C virus Antibody in blood donors with an ELISA method (in persian). Tehran University Medical Journal 2007;65:69-73.
60. Alavian SM, Miri SM, Keshvari M, Elizee PK, Behnava B, Tabatabaei SV, et al. Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia. Transfusion 2009;49:2195-2199.
61. Meena M, Jindal T, Hazarika A. Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: A five-year study. Transfusion 2011;51:198-202.
62. Rezvan H, Ahmadi J, Farhadi M, Tardyan S. A preliminary study of prevalence of HCV infection in healthy Iranian blood donors. Vox Sang 1994;67:149.
63. Sultan F, Mehmood T, Mahmood MT. Infectious pathogens in volunteer and replacement blood donors in Pakistan: A ten-year experience. Int J Infect Dis 2007;11:407-412.
64. Mahmoodian-Shooshtari M, Pourfathollah A. An overview analysis of blood donation in the Islamic Republic of Iran. Arch Iran Med 2006;9:200-203.
65. Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, et al. Prevalence, incidence, and residual risk of human immunodefciency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010;50:1495-1504.
66. Fallahian F, Najafi A, Alavian S. Intravenous drug use: The predominant risk factors for hepatitis C Virus Infection. Shiraz E-Medical Journal (SEMJ) 2010;11(4): 209-218.